Clin Chem:通过LC-MS/MS的淋巴细胞半乳糖脑苷脂酶活性进行新生儿Krabbe病筛查

2017-08-31 MedSci MedSci原创

近日,国际杂志 《Clinical Chemistry》上在线发表一项关于通过LC-MS/MS的淋巴细胞半乳糖脑苷脂酶活性进行新生儿Krabbe病筛查的研究。

近日,国际杂志 《Clinical Chemistry》上在线发表一项关于通过LC-MS/MS的淋巴细胞半乳糖脑苷脂酶活性进行新生儿Krabbe筛查的研究。

溶酶体酶半乳糖基前脑酶(GALC)缺乏会导致Krabbe病。Krabbe病的新生儿筛查需要改进对筛选阳性婴儿进行后续分析的方法,以更好地为家庭提供建议并优化治疗。研究人员报告了淋巴细胞中GALC的酶活性的新检测方法。

研究人员采用磁珠技术从静脉血中分离T淋巴细胞。该测定方法使用天然底物和LC-MS/MS的紧密结构类似物,借助于化学相同的内标来量化产物的量。测定的分析范围(QC高标准的测定反应与所有非酶依赖性过程的测定反应比例)比常规放射GALC测定的分析范围大20倍。LC-MS/MS可以从有活性酶痕迹的细胞中区分GALC中无效的细胞(低于正常值的0.3%)。淋巴细胞残留GALC活性水平与Krabbe病严重程度之间有很好的相关性。

与以前的测定相比,新的测定法可以高准确测量白细胞中少量残留的GALC活性,并且可以与基因分型,生物标志物分析和神经影像学一起进行,是一种更好新生儿Krabbe筛查随访计划。

原始出处:

Hsuan-Chieh Liao, Zdenek Spacil, Farideh Ghomashchi,et al. Lymphocyte Galactocerebrosidase Activity by LC-MS/MS for Post–Newborn Screening Evaluation of Krabbe Disease

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1981925, encodeId=785b198192581, content=<a href='/topic/show?id=c5b710566e8' target=_blank style='color:#2F92EE;'>#Krabbe病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10566, encryptionId=c5b710566e8, topicName=Krabbe病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 07 22:07:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302090, encodeId=ef57130209021, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sat Sep 02 13:07:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588733, encodeId=41dc1588e33a6, content=<a href='/topic/show?id=8ac523668e8' target=_blank style='color:#2F92EE;'>#乳糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23668, encryptionId=8ac523668e8, topicName=乳糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5a17619424, createdName=minzju5058, createdTime=Sat Sep 02 13:07:00 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1981925, encodeId=785b198192581, content=<a href='/topic/show?id=c5b710566e8' target=_blank style='color:#2F92EE;'>#Krabbe病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10566, encryptionId=c5b710566e8, topicName=Krabbe病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 07 22:07:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302090, encodeId=ef57130209021, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sat Sep 02 13:07:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588733, encodeId=41dc1588e33a6, content=<a href='/topic/show?id=8ac523668e8' target=_blank style='color:#2F92EE;'>#乳糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23668, encryptionId=8ac523668e8, topicName=乳糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5a17619424, createdName=minzju5058, createdTime=Sat Sep 02 13:07:00 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1981925, encodeId=785b198192581, content=<a href='/topic/show?id=c5b710566e8' target=_blank style='color:#2F92EE;'>#Krabbe病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10566, encryptionId=c5b710566e8, topicName=Krabbe病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Wed Mar 07 22:07:00 CST 2018, time=2018-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302090, encodeId=ef57130209021, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sat Sep 02 13:07:00 CST 2017, time=2017-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588733, encodeId=41dc1588e33a6, content=<a href='/topic/show?id=8ac523668e8' target=_blank style='color:#2F92EE;'>#乳糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23668, encryptionId=8ac523668e8, topicName=乳糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5a17619424, createdName=minzju5058, createdTime=Sat Sep 02 13:07:00 CST 2017, time=2017-09-02, status=1, ipAttribution=)]
    2017-09-02 minzju5058